SpyGlass Pharma, Inc.
SGP
$24.48
$0.341.41%
NASDAQ
| 12/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Net Income | -12.56M | -8.40M | |||
| Total Depreciation and Amortization | 216.70K | 107.50K | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | 443.40K | 1.39M | |||
| Change in Net Operating Assets | 2.56M | 652.70K | |||
| Cash from Operations | -9.33M | -6.25M | |||
| Capital Expenditure | -420.50K | -439.10K | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | 995.20K | 4.48M | |||
| Cash from Investing | 574.70K | 4.04M | |||
| Total Debt Issued | -- | -- | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | 19.80K | 142.60K | |||
| Repurchase of Common Stock | 0.00 | -- | |||
| Issuance of Preferred Stock | 300.00 | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -909.80K | -- | |||
| Cash from Financing | -889.60K | 142.60K | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | -9.65M | -2.06M | |||